Seeliger Lab

Ocular Neurodegeneration

Home » Labs » Seeliger Lab » Members » Regine Mühlfriedel

Regine Mühlfriedel

SurnameMühlfriedel
First nameRegine
NationalityGermany
Present position and titlePost-Doc, Gene Therapy Section Head, Dr. rer. nat.

Business address

Institute for Ophthalmic Research
Centre for Ophthalmology,
University of Tübingen
Elfriede-Aulhorn-Straße 7
72076 Tübingen
Germany

Phone: +49 (0)7071 29-87784
Fax: +49 (0)7071 29-4503
E-mail: regine.muehlfriedel[at]med.uni-tuebingen.de

Academic Education

Year Degree University Field of study
2006 Doctoral Thesis, Dr. rer. nat. Göttingen University, Germany Molecular Developmental Biology
2001 Diploma of Biology Jena University, Germany Molecular Genetics

Professional Experience

Period Institution Position Discipline
07/2011 Institute for Ophthalmic Research Tuebingen Senior Research Fellow Exp. Ophthalmology
07/2009 Institute for Ophthalmic Research Tuebingen Advanced Postdoctoral Research Fellow Exp. Ophthalmology
07/2006 Institute for Ophthalmic Research Tuebingen Postdoctoral Research Fellow Exp. Ophthalmology

Research Interests

  • Gene therapy
  • Animal model for hereditary retinal diseases
  • Retinal physiology and pathophysiology
  • Genotyping protocol establishment for transgenic mouse lines

Additional information

2002 - 2005 Member of post graduate programme »Genetics of Development«, Göttingen University, Germany

Membership

  • Association for Research in Vision and Ophthalmology (ARVO)

Publications

  1. Mühlfriedel R, Michalakis S, Garcia Garrido M, Biel M and Seeliger MW (2013) Optimized technique for subretinal injections in mice. In: Methods in Molecular Biology, Vol. 935: Retinal Degeneration: Methods and Protocols (Weber BH and Langmann T, eds), pp 343, New York: Humana Press.
  2. Gene therapy restores vision and delays degeneration in the CNGB1-/-mouse model of retinitis pigmentosa. Koch S, Sothilingam V, Garcia Garrido M, Tanimoto N, Becirovic E, Koch F, Seide C, Beck SC, Seeliger MW, Biel M, Mühlfriedel R, Michalakis S. Human Molecular Genetics. 2012 Oct 15;21(20):4486-96. Epub 2012 Jul 16.
  3. Gene therapy restores missing cone-mediated vision in the CNGA3-/- mouse model of achromatopsia. Michalakis S, Mühlfriedel R, Tanimoto N, Krishnamoorthy V, Koch S, Fischer MD, Becirovic E, Bai L, Huber G, Beck SC, Fahl E, Büning H, Schmidt J, Zong X, Gollisch T, Biel M, Seeliger MW. Advances in Experimental Medicine & Biology. 2012;723:183-9. No abstract available.
  4. A key role for cyclic nucleotide gated (CNG) channels in cGMP-related retinitis pigmentosa. Paquet-Durand F, Beck S, Michalakis S, Goldmann T, Huber G, Mühlfriedel R, Trifunović D, Fischer MD, Fahl E, Duetsch G, Becirovic E, Wolfrum U, van Veen T, Biel M, Tanimoto N, Seeliger MW. Human Molecular Genetics. 2011 Mar 1;20(5):941-7. Epub 2010 Dec 10.
  5. Restoration of cone vision in the CNGA3-/- mouse model of congenital complete lack of cone photoreceptor function. Michalakis S, Mühlfriedel R, Tanimoto N, Krishnamoorthy V, Koch S, Fischer MD, Becirovic E, Bai L, Huber G, Beck SC, Fahl E, Büning H, Paquet-Durand F, Zong X, Gollisch T, Biel M, Seeliger MW. Molecular Therapy. 2010 Dec;18(12):2057-63. Epub 2010 Jul 13.
  6. In vivo assessment of retinal vascular wall dimensions. Fischer MD, Huber G, Feng Y, Tanimoto N, Mühlfriedel R, Beck SC, Tröger E, Kernstock C, Preising MN, Lorenz B, Hammes HP, Seeliger MW. Investigative Ophthalmoly & Visual Science. 2010 Oct;51(10):5254-9. Epub 2010 May 5.
  7. Tanimoto N, Muehlfriedel R, Fischer MD, Fahl E, Humphries P, Biel M, Seeliger MW (2009) Vision tests in the mouse: functional phenotyping with electroretinography. Frontiers in Bioscience 14:2730-2737.